Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARP trial of simvastatin in acute lung injury
ISRCTN70127774Phase 2Completed
- Sponsor
- Royal Group of Hospitals
- Start
- Aug 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Reduction in extravascular lung water. Started Aug 2006; status: completed.
02
Drugs
simvastatin
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ISRCTN70127774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70127774.